Pharmaceutical manufacturers press for stricter control of compounding pharmacies

On October 10th, 2012, posted in: Rx Returns by

Tags: , , , ,

A national fungal meningitis outbreak linked to contaminated vials of steroid injectables from a Massachusetts compounding operation has reignited the debate over the safety of compounded drugs and the need for stiffer FDA regulation of these activities. Last week, the Centers for Disease Control and Prevention (CDC) reported 7 deaths and 91 ill, with the […]

read more